Laboratorio de Imunologia, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Laboratorio de Investigaçao Medica 19 (LIM-19), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
Am J Reprod Immunol. 2024 Mar;91(3):e13830. doi: 10.1111/aji.13830.
Endometriosis exhibits several immune dysfunctions, including deficient natural killer (NK) cell cytotoxicity. MICA (MHC class I chain-related molecule A) is induced by biological stress and soluble MICA (sMICA) negatively modulates the expression of the activating receptor, NKG2D, reducing NK cells activities. We investigated the involvement of soluble MICA in NK cell-deficient activity in endometriosis.
sMICA levels (serum and peritoneal fluid-PF) were evaluated by ELISA. Circulating NK cell subsets quantification and its NKG2D receptor expression, NK cell cytotoxicity and CD107a, IFN-γ and IL-10 expressions by NK cells stimulated with K562 cells were determined by flow cytometry.
We found higher sMICA levels (serum and PF) in endometriosis, especially in advanced and deep endometriosis. Endometriosis presented lower percentages of CD56 CD16+ cytotoxic cells and impaired NK cell responses upon stimulation, resulting in lower CD107a and IFN-γ expressions, and deficient NK cell cytotoxicity. NK cell stimulation in the MICA-blocked condition (mimicking the effect of sMICA) showed decreased cytotoxicity in initial endometriosis stages and the emergence of a negative correlation between CD107a expression and sMICA levels.
We suggest that soluble MICA is a potential player in endometriosis pathophysiology with involvement in disease progression and severity, contributing to NK cell impaired IFN-γ response and degranulation. NK cell compartment exhibits multiple perturbations, including quantitative deficiency and impaired cytotoxicity, contributing to inadequate elimination of ectopic endometrial tissue.
子宫内膜异位症表现出多种免疫功能障碍,包括自然杀伤 (NK) 细胞细胞毒性不足。MICA(MHC Ⅰ类链相关分子 A)受生物应激诱导,可溶性 MICA(sMICA)负调节激活受体 NKG2D 的表达,降低 NK 细胞的活性。我们研究了可溶性 MICA 在子宫内膜异位症中 NK 细胞活性不足中的作用。
通过 ELISA 评估 sMICA 水平(血清和腹腔液-PF)。通过流式细胞术检测循环 NK 细胞亚群的定量及其 NKG2D 受体表达、NK 细胞对 K562 细胞的刺激后的细胞毒性以及 CD107a、IFN-γ 和 IL-10 的表达。
我们发现子宫内膜异位症中 sMICA 水平(血清和 PF)升高,尤其是在晚期和深部子宫内膜异位症中。子宫内膜异位症中 CD56CD16+细胞毒性细胞的比例较低,NK 细胞刺激后的反应受损,导致 CD107a 和 IFN-γ 的表达降低,NK 细胞的细胞毒性降低。在 MICA 阻断条件下(模拟 sMICA 的作用)刺激 NK 细胞显示出在初始子宫内膜异位症阶段的细胞毒性降低,并且 CD107a 表达与 sMICA 水平之间出现负相关。
我们认为可溶性 MICA 是子宫内膜异位症病理生理学中的一个潜在因素,参与疾病的进展和严重程度,导致 NK 细胞 IFN-γ 反应和脱颗粒受损。NK 细胞群表现出多种紊乱,包括数量不足和细胞毒性受损,导致异位子宫内膜组织的清除不足。